4.4 Letter

Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not)

Journal

CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 72, Issue 2, Pages 489-490

Publisher

SPRINGER
DOI: 10.1007/s00280-013-2213-y

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available